These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 18622684)

  • 1. Penetration into and exposure of cefozopran in pelvic retroperitoneal space exudate.
    Ikawa K; Mikamo H; Morikawa N; Ikeda K; Tamaya T
    J Infect Chemother; 2008 Apr; 14(2):170-1. PubMed ID: 18622684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritoneal penetration and pharmacodynamic exposure of intravenous cefozopran in abdominal surgery patients.
    Ikawa K; Morikawa N; Matsuda S; Ikeda K; Ohge H; Takesue Y; Sueda T
    Int J Antimicrob Agents; 2007 Oct; 30(4):352-5. PubMed ID: 17644344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritoneal pharmacokinetics of cefepime in laparotomy patients with inflammatory bowel disease, and dosage considerations for surgical intra-abdominal infections based on pharmacodynamic assessment.
    Higuchi K; Ikawa K; Ikeda K; Ohge H; Sueda T; Houchi H; Morikawa N
    J Infect Chemother; 2008 Apr; 14(2):110-6. PubMed ID: 18622673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of miconazole in serum and exudate of pelvic retroperitoneal space after radical hysterectomy and pelvic lymphadenectomy.
    Mikamo H; Kawazoe K; Sato Y; Ito K; Tamaya T
    Int J Antimicrob Agents; 1997 Jan; 9(3):207-11. PubMed ID: 9552718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of cephem antibiotics in exudate of pelvic retroperitoneal space after radical hysterectomy and pelvic lymphadenectomy.
    Ito K; Hayasaki M; Tamaya T
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1160-4. PubMed ID: 2393276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefepime pharmacodynamics in patients with extended spectrum beta-lactamase (ESBL) and non-ESBL infections.
    Lee SY; Kuti JL; Nicolau DP
    J Infect; 2007 May; 54(5):463-8. PubMed ID: 17067681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on antimicrobial concentrations of flomoxef in serum, pelvic dead space exudate, and pelvic organs/tissues].
    Obata T; Koishi K; Sasaki J; Eguchi M; Yamamoto Y
    Jpn J Antibiot; 1987 Oct; 40(10):1820-9. PubMed ID: 3444023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimized dosage and frequency of cefozopran for patients with febrile neutropenia based on population pharmacokinetic and pharmacodynamic analysis.
    Nomura K; Morikawa N; Ikawa K; Ikeda K; Fujimoto Y; Shimizu D; Taniguchi K; Shimura K; Kanbayashi Y; Komori T; Matsumoto Y; Fujita N; Shimazaki C; Taniwaki M
    J Antimicrob Chemother; 2008 Apr; 61(4):892-900. PubMed ID: 18276604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units.
    Roos JF; Bulitta J; Lipman J; Kirkpatrick CM
    J Antimicrob Chemother; 2006 Nov; 58(5):987-93. PubMed ID: 16943209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penetration and exposure of cefotiam into the peritoneal fluid of abdominal surgery patients after intravenous administration.
    Ikawa K; Morikawa N; Fukuhara K; Hayato S; Ikeda K; Soga Y; Ohge H; Sueda T
    J Chemother; 2008 Jun; 20(3):319-23. PubMed ID: 18606586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic-pharmacodynamic target attainment analysis of cefozopran in Japanese adult patients.
    Ikawa K; Nomura K; Morikawa N; Ikeda K; Ohge H; Sueda T; Taniwaki M
    J Infect Chemother; 2008 Apr; 14(2):130-6. PubMed ID: 18622676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneal penetration of doripenem after intravenous administration in abdominal-surgery patients.
    Ikawa K; Morikawa N; Urakawa N; Ikeda K; Ohge H; Sueda T
    J Antimicrob Chemother; 2007 Dec; 60(6):1395-7. PubMed ID: 17884833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacokinetics of flomoxef in prostate tissue and dosing considerations for prostatitis based on site-specific pharmacodynamic target attainment.
    Nakamura K; Ikawa K; Nishikawa G; Kobayashi I; Tobiume M; Sugie M; Muramatsu H; Morinaga S; Kajikawa K; Watanabe M; Kanao K; Onita T; Morikawa N
    J Infect Chemother; 2020 Feb; 26(2):236-241. PubMed ID: 31822449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetic, bacteriological and clinical studies of cefuzonam in the field of obstetrics and gynecology].
    Ito K; Iida K; Kondo H; Noda K; Hayasaki M; Sumi H; Kadomoto N
    Jpn J Antibiot; 1987 May; 40(5):1066-73. PubMed ID: 3669285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic Evaluation of Fosfomycin against Escherichia coli and Klebsiella spp. from Urinary Tract Infections and the Influence of pH on Fosfomycin Activities.
    Fedrigo NH; Mazucheli J; Albiero J; Shinohara DR; Lodi FG; Machado ACDS; Sy SKB; Tognim MCB
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28607025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic and pharmacodynamic profiling of cefepime in plasma and peritoneal fluid of abdominal surgery patients.
    Ikawa K; Morikawa N; Hayato S; Ikeda K; Ohge H; Sueda T
    Int J Antimicrob Agents; 2007 Sep; 30(3):270-3. PubMed ID: 17587550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of breakpoints of cephems for intraabdominal infections based on pharmacokinetics and pharmacodynamics in the peritoneal fluid of patients.
    Ikawa K; Morikawa N; Ikeda K; Ohge H; Sueda T
    J Infect Chemother; 2008 Apr; 14(2):141-6. PubMed ID: 18622678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Penetration of cefoperazone into the exudate of the retroperitoneal space after (semi-)radical hysterectomy].
    Nozawa S; Tsai DZ; Jeng CH; Kojima M; Tsutsui F; Izumi S; Kurihara S
    Jpn J Antibiot; 1986 Mar; 39(3):686-92. PubMed ID: 3735663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetics and pharmacodynamics of meropenem in the cerebrospinal fluid of neurosurgical patients.
    Tsumura R; Ikawa K; Morikawa N; Ikeda K; Shibukawa M; Iida K; Kurisu K
    J Chemother; 2008 Oct; 20(5):615-21. PubMed ID: 19028626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetic studies on ceftazidime in the obstetrical and gynecological field].
    Ito K; Kondo H; Hayasaki M; Noda K
    Jpn J Antibiot; 1984 Jan; 37(1):18-22. PubMed ID: 6374194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.